Dr. Shiv Singh
Shiv Singh is a Principal Investigator of SP2 and a member of the Selection Comittee.
His research focus lies on epigenetic and transcriptional networks in Pancreatic Ductal Adenocarcinoma (PDAC) heterogeneity and therapy response.
Dr. Singh is a faculty and advisory committee member of the International Max Planck Research School for Genome Science graduate school (IMPRS-GS), PI in the Clinician Scientist Program “Cell Dynamics in pathogenesis and therapy” at the UMG Promotionskolleg for MD students, and a faculty and examination committee member of the University of Göttingen graduate Schools (GGNB, GAUSS, DNB and UMG). In addition, he teaches Cancer Biology to M.Sc. students (DNB program), and Bionmedical Sciences to MD students.
| Year | Position |
|---|---|
| Since 2022 | Extension of Max-Eder Group Leader position, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| Since 2018 | Max-Eder Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| 2016-2017 | Junior Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| 2014-2016 | Postdoctoral Fellow at Barrow Neurological Institute, Phoenix, USA |
| 2011-2014 | Postdoctoral Fellow at Philipps-University of Marburg |
| 2006-2010 | Dr. rer. physiol (summa cum laude), Philipps-University of Marburg (Supervisor: Prof. Volker Ellenrieder) |
| 2002-2004 | Master of Science in Biochemistry, University of Bundelkhand, India |